Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IMMUNIC, INC. | 150,000 | reported | 05 Jun 2025 | tx 3+300,000 |
| Atrium Therapeutics, Inc. | 20,000 | reported | 27 Feb 2026 | tx 1+20,000 |
| Avidity Biosciences, Inc. | 0 | reported | 27 Feb 2026 | tx 6+59,034−59,034 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | GRANT_AWARD | Atrium Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 6,692 | — | |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 10,034 | — | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 42,308 | — | deriv |
| 10 Jun 2025 | GRANT_AWARD | Avidity Biosciences, Inc. | 6,692 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Avidity Biosciences, Inc. | 10,034 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | IMMUNIC, INC. | 150,000 | 0.00 USD | deriv |
| 22 Jul 2024 | GRANT_AWARD | IMMUNIC, INC. | 50,000 | 0.00 USD | deriv |
| 22 Jul 2024 | GRANT_AWARD | IMMUNIC, INC. | 100,000 | 0.00 USD | deriv |
| 14 May 2024 | GRANT_AWARD | Avidity Biosciences, Inc. | 42,308 | 0.00 USD | deriv |